
Results
13
Companies that are expected to sustainably pay a dividend that beats your savings account (over 3%).
13 companies
Roche Holding
Market Cap: CHF 268.0b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 312.90
7D
0.9%
1Y
23.9%
Merck
Market Cap: US$262.3b
Operates as a healthcare company worldwide.
MRK
US$104.63
7D
10.1%
1Y
1.5%
Sanofi
Market Cap: €104.9b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€86.23
7D
0.3%
1Y
-6.6%
Bristol-Myers Squibb
Market Cap: US$99.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$49.25
7D
7.6%
1Y
-16.9%
Takeda Pharmaceutical
Market Cap: JP¥7.2t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,535.00
7D
2.8%
1Y
10.8%
Astellas Pharma
Market Cap: JP¥3.6t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,983.00
7D
3.6%
1Y
26.5%
Krka d. d
Market Cap: €6.2b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€204.00
7D
-1.0%
1Y
47.3%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥47.6b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥28.59
7D
-2.1%
1Y
-19.6%
Ono Pharmaceutical
Market Cap: JP¥1.0t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,169.00
7D
7.9%
1Y
26.5%
Hikma Pharmaceuticals
Market Cap: UK£3.5b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£15.60
7D
-1.1%
1Y
-20.3%
Livzon Pharmaceutical Group
Market Cap: CN¥29.8b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥36.13
7D
0.3%
1Y
-2.1%
Tasly Pharmaceutical Group
Market Cap: CN¥23.1b
Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.
600535
CN¥15.47
7D
1.6%
1Y
5.0%
Tsumura
Market Cap: JP¥289.7b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,897.00
7D
3.8%
1Y
-18.8%